News

News Articles

1. Interviews, Kanvas Bio

   16, Aug, 2024

   Wel­come, Drs. Mar­guerite Pri­or and Kevin Keomanee-Dizon!

2. External news, Forbes

   01, Jul, 2024

   This Biotech Start­up Raised $12.5 Mil­lion To Find Bac­te­ria That Help Fight Cancer

3. Press releases, Kanvas Bio

   01, Jul, 2024

   With $12.5M in New Fund­ing, Kan­vas Bio is Advanc­ing its Nov­el, Micro­bio­me-Based, Immuno-oncol­o­gy Drug Candidates

4. Press releases, Kanvas Bio

   21, Jun, 2024

   Intro­duc­ing the Next Drug Can­di­date in Kan­vas Bio’s Immuno-Oncol­o­gy Pro­gram: KAN-003

5. Interviews, The Economist

   17, Apr, 2024

   CEO Matt Cheng dis­cuss­es the micro­bio­me on The Econ­o­mist’s Bab­bage podcast

6. Interviews, Kanvas Bio

   15, Mar, 2024

   End­points News’ Ven­ture Invest­ing in Biotech Webi­nar Got Us Fired Up

7. External news, MedCity News

   29, Feb, 2024

   It’s Time to Evolve Beyond FMTs and Advance LBPs

8. Interviews, Kanvas Bio

   26, Jan, 2024

   Kan­vas Bio’s State of the Art AI Mod­els & Reflec­tions from JPM 2024

9. Interviews, Kanvas Bio

   19, Dec, 2023

   Kan­vas Bio Annu­al Sci­ence Day Recap

10. External news, DCVC

    11, Oct, 2023

    With Assets from Fed­er­a­tion Bio, Kan­vas Aims to Replace Impre­cise Micro­bio­me Ther­a­pies with a Sin­gle, Ratio­nal­ly Designed Pill